• Bright Minds Biosciences will hold its annual general meeting in Vancouver, British Columbia on March 31, 2026.
• Shareholders will receive the company’s audited consolidated financial statements for the fiscal year ended Sept. 30, 2025.
• Items up for vote include the election of directors and the appointment of De Visser Gray LLP as auditor, with remuneration set by directors.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bright Minds Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001062993-26-003005), on June 03, 2026, and is solely responsible for the information contained therein.